Search
for
Sort by
Research
990-1000 / 1000+ results![A Retrospective Analysis of Dermatoses in the Perimenopausal Population Attending a Tertiary Care Centre in South India](/images/research/72d627e5-eeaf-4a55-9284-13efcd92e51e/small/18715.jpg)
research A Retrospective Analysis of Dermatoses in the Perimenopausal Population Attending a Tertiary Care Centre in South India
The most common skin problems in perimenopausal women in South India are infections, eczemas, and acne, possibly worsened by external factors and lifestyle practices.
![Examining Cutaneous Disease Activity as an Outcome Measure for Clinical Trials in Dermatomyositis](/images/research/2092f32c-3cd8-4ee6-a91e-c4356ef63bad/small/13638.jpg)
research Examining Cutaneous Disease Activity as an Outcome Measure for Clinical Trials in Dermatomyositis
Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.
![The Disease Spectrum, Epidemiology, and Etiology of Toxic-Shock Syndrome](/images/research/9f148b64-e1c0-4326-b138-e8719e85a652/small/25466.jpg)
research The Disease Spectrum, Epidemiology, and Etiology of Toxic-Shock Syndrome
Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.
![Defining Chronic Wound Types in Recessive Dystrophic Epidermolysis Bullosa Patients for Clinical Outcome Assessment](/images/research/53f44e9f-1755-48c5-b6be-719c58e8bde3/small/13582.jpg)
research Defining Chronic Wound Types in Recessive Dystrophic Epidermolysis Bullosa Patients for Clinical Outcome Assessment
The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.
![Outcome of Long-Term Treatment with the 5α-Reductase Inhibitor Finasteride in Idiopathic Hirsutism: Clinical and Hormonal Effects During a 1-Year Course of Therapy and 1-Year Follow-Up](/images/research/a61473f7-968b-43fd-9580-52ca7b81cb40/small/2131.jpg)
research Outcome of Long-Term Treatment with the 5α-Reductase Inhibitor Finasteride in Idiopathic Hirsutism: Clinical and Hormonal Effects During a 1-Year Course of Therapy and 1-Year Follow-Up
Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.
![Autologous Micrografts from Scalp Tissue: Trichoscopic and Long-Term Clinical Evaluation in Male and Female Androgenetic Alopecia](/images/research/ccaef4c0-f04f-4d6e-882d-0524a6e91cd0/small/4721.jpg)
research Autologous Micrografts from Scalp Tissue: Trichoscopic and Long-Term Clinical Evaluation in Male and Female Androgenetic Alopecia
Micrografts improve hair density and thickness without side effects.
![Clinical and Hormonal Effects of the 5 Alpha-Reductase Inhibitor Finasteride in Idiopathic Hirsutism](/images/research/08fb9774-00b4-41b2-bef3-2257730ff2a3/small/2050.jpg)
research Clinical and Hormonal Effects of the 5 Alpha-Reductase Inhibitor Finasteride in Idiopathic Hirsutism
Finasteride reduces hair growth and is safe for women with excessive hair.
![Clinical Management of Cutaneous Adverse Events in Patients on Targeted Anticancer Therapies and Immunotherapies: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology](/images/research/897e5056-3ccf-44a5-8c13-9a090056421f/small/24055.jpg)
research Clinical Management of Cutaneous Adverse Events in Patients on Targeted Anticancer Therapies and Immunotherapies: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.
![Surrogate End-Points or Primary Outcomes in Clinical Trials in Women with Polycystic Ovary Syndrome?](/images/research/495f7780-ce7a-40ce-b1fb-901045748eb3/small/21033.jpg)
research Surrogate End-Points or Primary Outcomes in Clinical Trials in Women with Polycystic Ovary Syndrome?
The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.